Kyle M. Hatten
Papers
5
Total Citations
83
H-Index
3
About
Dr. Kyle M. Hatten is a head and neck oncologic surgeon whose research centers on advancing minimally invasive treatments for oropharyngeal cancer, particularly HPV-positive disease. His most impactful work, a 2016 study on transoral robotic surgery (TORS)-assisted endoscopy for occult mucosal primaries (69 citations), established a paradigm for identifying hidden tumors in patients presenting with cervical metastases—reducing the need for broad, morbid radiotherapy. Dr. Hatten has since led multiple clinical trials refining de-escalation strategies, including the SAVER trial (2024), which selectively avoids nodal volumes in the contralateral N0 neck of p16-positive patients, and studies combining TORS with proton beam therapy to minimize toxicity. His 2025 analysis of margin status in radical tonsillectomy specimens and research on nutritional outcomes after TORS demonstrate a sustained commitment to optimizing both oncologic control and functional recovery. Through these contributions, Dr. Hatten is helping define a future where patients with HPV-positive oropharynx cancer receive precisely targeted, less debilitating treatment—a shift with profound implications for quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5